Jennifer Pellowski

Dr. Jennifer Pellowski

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2017 in Psychology & Health
Verified
Journal Article
Closed access
JPJennifer Pellowski
Jennifer Pellowski
DPDevon M. Price
Devon M. Price
AAAerielle M. Allen
Aerielle M. Allen
LELisa A. Eaton
Lisa A. Eaton
SKSeth C. Kalichman
Seth C. Kalichman
Objective: The purpose of this study was to examine the relationships between medical mistrust and trust and to determine if these measures differentially predict antiretroviral therapy (ART) medication adherence for African-American adults living with HIV. Design: A total of 458 HIV positive African-Americans completed a cross-sectional survey. Main Outcome Measures: Self-reported ART adherence was collected using the visual-analog scale. The Beliefs About Medicines Questionnaire was used to assess medication necessity and concern beliefs. Results: All measures of medical mistrust and trust were significantly negatively correlated, ranging from r = −.339 to −.504. Race-based medical mistrust significantly predicted medication necessity and concern beliefs, whereas general medical mistrust only significantly predicted medication concerns. Both measures of trust significantly predicted medication necessity beliefs and medication concerns. Higher levels of race-based medical mistrust predicted lower medication adherence, whereas, neither trust in own physician nor trust in health care provider significantly predicted medication adherence. However, trust in own physician significantly predicted medication necessity beliefs, which predicted medication adherence. Conclusion: Trust and mistrust are not simply opposites of one another. These findings provide evidence for the complexity of understanding the relationship between health care trust, mistrust and patient-related health beliefs and behaviours.

1 December 2019 in Journal of Affective Disorders
Verified
Journal Article
Open access
JPJennifer Pellowski
Jennifer Pellowski
ABAngela M. Bengtson
Angela M. Bengtson
WBWhitney Barnett
Whitney Barnett
KDKira DiClemente-Bosco
Kira DiClemente-Bosco
NKNastassja Koen
Nastassja Koen
DSDan J. Stein
Dan J. Stein
Perinatal depression affects 21-50% of women in South Africa and poses significant health risks to mothers and children. Trajectories of depressive symptoms change over time and have not been well characterized during the perinatal period in low and middle-income countries. Data from women enrolled in a population-based birth cohort study in Paarl, South Africa with at least 3 depression measures from pregnancy through 18 months postpartum (N = 831) were analyzed. Depressive symptoms were measured continuously using the Edinburgh Postnatal Depression Scale (EPDS). Group-based trajectory models were used to estimate trajectories of depressive symptoms during the perinatal period and multinomial multivariable models to identify predictors of trajectory group membership. Five distinct trajectory patterns of depressive symptoms were identified: moderate levels of depressive symptoms during pregnancy but minimal postpartum (3.5%), minimal levels during pregnancy and increasing postpartum (3.7%), unstable levels peaking at 12 months postpartum (6.6%), mild levels with slight decrease postpartum (82.9%), and severe levels during pregnancy and postpartum (3.1%). Membership in the chronic severe symptom group was associated with stressful life events, sexual intimate partner violence and tobacco use. Modeling limitations prevented determining how changes in psychosocial predictors over time may influence depressive symptom trajectories. Mild to severe depressive symptoms during pregnancy/postpartum were common among this South African cohort. Interventions to treat women with severe chronic depressive symptoms with co-occurring psychosocial issues are urgently needed.

15 November 2018 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
JPJennifer Pellowski
Jennifer Pellowski
DPDevon M. Price
Devon M. Price
AHAbigail D. Harrison
Abigail D. Harrison
ETEmily L. Tuthill
Emily L. Tuthill
LMLandon Myer
Landon Myer
MLMark N. Lurie
Mark N. Lurie

10 March 2016 in AIDS Care
Verified
Journal Article
Closed access
JPJennifer Pellowski
Jennifer Pellowski
SKSeth C. Kalichman
Seth C. Kalichman
MKMoira O. Kalichman
Moira O. Kalichman
CCChauncey Cherry
Chauncey Cherry
Alcohol-antiretroviral therapy (ART) interactive toxicity beliefs reflect perceived adverse outcomes of mixing alcohol and ART. Previous research has shown a significant relationship between alcohol-ART interactive toxicity beliefs and ART non-adherence, over and above other correlates of non-adherence such as human immunodeficiency virus (HIV)symptoms and frequency of alcohol use. Most past studies have collected data over extended periods and have not determined if alcohol use and missed medications occur at the day-level among people holding interactive toxicity beliefs. Previous daily analyses, however, have been limited by self-reported adherence and relatively short periods of observation. To address these gaps in the literature, men and women living with HIV in Atlanta, GA, were enrolled in a 45-day observational cohort study. Daily alcohol use was collected using two-way interactive text message surveys and daily adherence was collected via the Wisepill device. Fifty-seven participants completed a measure of alcohol-ART interactive toxicity beliefs and contributed 2565 days of daily data. Participants who endorsed high levels of interactive toxicity beliefs had significantly more days when they missed doses of medication. Alcohol-antiretroviral toxicity beliefs predicted missing doses of medication on days when participants were drinking and on days when they were not drinking. Multilevel multivariate regressions showed that these toxicity beliefs predicted daily missed doses of medication over and above quantity of alcohol consumed, depression and general medication concerns. This study replicates and extends previous literature and indicates the necessity of addressing alcohol-ART toxicity beliefs within adherence interventions.

15 December 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
JPJennifer Pellowski
Jennifer Pellowski
CWCatherine Wedderburn
Catherine Wedderburn
JSJacob A M Stadler
Jacob A M Stadler
WBWhitney Barnett
Whitney Barnett
DSDan Stein
Dan Stein
HZHeather J Zar
Heather J Zar
Objectives The coverage of prevention of mother-to-child transmission (PMTCT) services in South Africa is variable. Identifying gaps in the implementation of these services is necessary to isolate steps needed to further reduce paediatric infections and eliminate transmission. Setting Two primary care clinics in Paarl, South Africa. Participants 1225 pregnant women; inclusion criteria were 18 years or older, clinic attendance and remaining in area for at least 1 year. Methods Data were collected through the Drakenstein Child Health Study, a population-based birth cohort in a periurban area of the Western Cape, South Africa. A combination of clinic records, hospital records, national database searches and maternal self-report were collected during the study. Results Of the 1225 mothers enrolled in the cohort between 2012 and 2015, 260 (21%) were confirmed HIV infected antenatally and 1 mother tested positive in the postnatal period. Of those with documentation (n=250/260, 96%), the majority (99%) received antiretroviral prophylaxis or therapy (ART) before labour; however, there was a high rate of defaulting from ART noted during pregnancy (20%). All HIV-exposed infants with data received antiretroviral prophylaxis, 35% were exclusively breast fed until 6 weeks and 16% for 6 months. There were two cases of infant HIV infection (0.8%) who were initiated on ART but had complicated histories. Conclusion Despite the low transmission rate in this cohort, reaching elimination will require further work, and this study illustrates several areas to improve implementation of PMTCT services and reduce paediatric infections including retesting at-risk HIV-negative mothers through the duration of breast feeding, infant HIV testing at any admission in addition to routine testing and improved counselling to prevent defaulting from treatment. Better data surveillance systems are essential for determining the implementation of PMTCT guidelines.

1 August 2017 in Social Science & Medicine
Verified
Journal Article
Closed access
JPJennifer Pellowski
Jennifer Pellowski
WBWhitney Barnett
Whitney Barnett
CKCaroline C. Kuo
Caroline C. Kuo
NKNastassja Koen
Nastassja Koen
HZHeather J. Zar
Heather J. Zar
DSDan J. Stein
Dan J. Stein